Key Record Dates
ClinicalTrials.gov Identifier: | NCT00843440 |
---|---|
Brief Title: | Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study (METAFORE) |
First Submitted : | February 12, 2009 |
First Submitted that Met QC Criteria : | February 12, 2009 |
First Posted : | February 13, 2009 (Estimate) |
Last Update Submitted that Met QC Criteria : | May 29, 2013 |
Last Update Posted : | May 30, 2013 (Estimate) |